Abstract
Post-translational modifications of proteins, such as acetylation, are important regulatory events in eukaryotic cells. Reversible acetylations of histones and non-histone proteins regulate gene expression and protein activity. Acetylation levels of proteins are regulated by a dynamic equilibrium between acetylation by (histone) acetyltransferases and deacetylation by (histone) deacetylases. Alterations in this equilibrium can result in pathological states. Inflammation is a physiological response that, under certain conditions, turns into a disease. This review focuses on the crucial regulatory roles of protein acetylation in NF-kappa B-mediated inflammation and the potential applications of small-molecule inhibitors of acetylation for the treatment of inflammatory diseases.
Original language | English |
---|---|
Pages (from-to) | 504-511 |
Number of pages | 8 |
Journal | Drug Discovery Today |
Volume | 16 |
Issue number | 11-12 |
DOIs | |
Publication status | Published - Jun-2011 |
Keywords
- DEPENDENT GENE-EXPRESSION
- CREB-BINDING PROTEIN
- SMOOTH-MUSCLE-CELLS
- H4 ACETYLATION
- ANACARDIC ACID
- IN-VIVO
- TRANSCRIPTIONAL ACTIVATION
- CHROMATIN TRANSCRIPTION
- DEACETYLASE ACTIVITY
- LUNG INFLAMMATION